Max Robotics — Global Service Robot Directory + US Certification

About

Brian T. Helfand is a urologic surgeon and researcher whose work focuses on advancing surgical techniques for prostate conditions, particularly through robotic-assisted and minimally invasive approaches. His major contributions center on improving the efficiency, safety, and cost-effectiveness of prostate surgeries. Notably, his highly cited 2011 paper on "Simple Modifications in Operating Room Processes to Reduce the Times and Costs Associated with Robot-Assisted Laparoscopic Radical Prostatectomy" (32 citations) demonstrated how streamlining surgical workflows can significantly lower expenses without compromising patient outcomes. More recently, Dr. Helfand has pioneered same-day discharge protocols for robotic-assisted aquablation prostate surgery, as highlighted in his 2024 study (8 citations), which shows the feasibility and safety of performing these procedures in ambulatory surgery centers. He has also contributed to standardizing aquablation treatment for benign prostatic hyperplasia (2022, 6 citations), a less invasive alternative to traditional surgery. Additionally, his case report on clear cell renal cell carcinoma with osseous metaplasia (2011, 7 citations) adds to the rare literature on this unusual histologic finding. Through his research, Dr. Helfand continues to shape modern urologic practice by making prostate surgery more accessible, efficient, and patient-friendly.